Diamond Therapeutics has announced that the first patient has been enrolled in its FDA-authorised UAB-Diamond trial evaluating low-dose psilocybin in patients with demoralization.
Researchers from the University of Southern Denmark have established a psilocybin microdosing regimen in rats to help advance microdosing research.
Three promising studies featuring psilocybin, LSD and MDMA have shown signs of improved brain function.
A social poll by the healthy living and aging platform, Goldster, revealed that over 65s are more open to trying microdosing than those under the age...
The ‘Microdosing and Meditation Study’ is aiming to observe how meditation skills evolve over three months of regular meditation practice and whether, how, and for whom...
The Microdosing Collective has stated it is committed to a world where sub-perceptible microdosing of psychedelics is legal, accessible and safe.
Results from the largest longitudinal study investigating the practice of microdosing psilocybin for mental health, and one of the few to use a control group, have...
Mindset Pharma and Canada’s top psychiatric research hospital, CAMH, have entered into a collaboration to build the molecular profile of MSP-1014 compared to psilocybin.
A company is addressing concerns over the medical application of microdosing by developing a molecule that could eliminate the potential risk of heart damage.
A recent study testing the impact of microdosing LSD has suggested the practice has no therapeutic or cognitive effects.
